全球 API 中间体市场 – 行业趋势和 2030 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Pharmaceutical Global Api Intermediates Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球 API 中间体市场 – 行业趋势和 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Sep 2023
  • Global
  • 350 页面
  • 桌子數： 220
  • 图号： 60
立即购买 立即购买

Global Api Intermediates Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 2023 –2030
Diagram Market Size (Base Year)
 USD 2.34 Billion
Diagram Market Size (Forecast Year)
 USD 5.67 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • HIKAL Ltd
  • Cambrex Corporation
  • Ganesh Group
  • AlzChem Group AG
  • Vasudha Pharma

>全球 API 中间体市场，按类型（兽药中间体、制药 / 大宗药物中间体）、产品（溴化合物、O-苄基沙丁胺醇、半硫酸盐、环氧乙烷、比索洛尔碱、手性 PCBHP、非那敏碱、氯苯那敏碱、溴苯那敏碱、美吡拉敏/吡拉明碱、6-氨基-1,3-二甲基尿嘧啶、茶碱、乙酰茶碱、黄嘌呤、腈类、其他）、治疗类型（自身免疫性疾病、肿瘤学、代谢性疾病、眼科学、心血管疾病、传染病、神经病学、呼吸系统疾病、皮肤病学、泌尿科、其他）、客户（直接用户 / 制药公司、贸易商 / 批发商 / 分销商、协会 / 政府机构 / 私人机构）、最终用户（API 制造商、成品产品制造商）、分销渠道（直接招标、零售销售、其他）——行业趋势和预测到 2030 年。

API 中间体市场

全球 API 中间体市场分析及规模

活性药物成分 是用于制造药品的物质或物质组合，当用于生产药品时，即成为活性药物成分。此类物质用于提供药理活性。             

Data Bridge Market Research 分析称，2022 年全球 API 中间体市场规模为 23.4 亿美元，预计到 2030 年将达到 56.7 亿美元，预计在 2023-2030 年的预测期内复合年增长率为 7.10%。由于制药行业的兴起，“制药/原料药中间体”在全球 API 中间体市场类型细分市场中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

API 中间体市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2021)

定量单位

收入（百万美元）、销量（单位）、定价（美元）

涵盖的领域

类型（兽药中间体、医药/大宗药物中间体）、产品（溴化合物、O-苄基沙丁胺醇、半硫酸盐、环氧乙烷、比索洛尔碱、手性 PCBHP、非那敏碱、氯苯那敏碱、溴苯那敏碱、美吡拉敏/吡拉明碱、6-氨基-1,3-二甲基尿嘧啶、茶碱、乙酰茶碱、黄嘌呤、腈类、其他）、治疗类型（自身免疫性疾病、肿瘤学、代谢性疾病、眼科、心血管疾病、传染病、神经病学、呼吸系统疾病、皮肤病学、泌尿科、其他）、客户（直接用户/制药公司、贸易商/批发商/分销商、协会/政府机构/私人机构）、最终用户（API 制造商、成品制造商）、分销渠道（直接投标、零售、其他）

覆盖国家

美国、加拿大、墨西哥、德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、奥地利、挪威、匈牙利、立陶宛、爱尔兰、波兰、欧洲其他地区、日本、中国、澳大利亚、印度、韩国、新加坡、印度尼西亚、泰国、马来西亚、菲律宾、越南、亚太其他地区、巴西、阿根廷、秘鲁、南美洲其他地区、沙特阿拉伯、南非、阿联酋、以色列、科威特、埃及以及中东和非洲其他地区

涵盖的市场参与者
  • HIKAL Ltd.（印度）、Cambrex Corporation（美国）、Ganesh-Group、AlzChem Group AG（印度）、Vasudha Pharma（印度）、安阳化工总公司（中国）、Sarex（印度）、Sandoo Pharmaceuticals and Chemicals Co., Ltd（印度）、Atul Ltd（印度）、Sandoz International GmbH（诺华公司子公司）（德国）、Aceto（美国）、Supriya Lifescience Ltd.（印度）、LEVACHEM COMPANY LIMITED（中国）、Vertellus（美国）、Dishman Carbogen Amcis Ltd（印度）、Sanofi（法国）、Divi's Laboratories Limited（印度）、AARTI INDUSTRIES LIMITED（印度）、Aurobindo Pharma（印度）、BASF SE（德国）

市场机会
  • 个性化医疗需求日益增长
  • 加强合作与伙伴关系
  • 更加关注绿色和可持续化学

市场定义

在讨论药物和化学合成时，“API 中间体”一词是指在漫长的合成活性药物成分 (API) 过程中产生的许多化学化合物和材料。药物的活性成分 (API) 是赋予药物治疗作用的成分。API 的创建通常需要进行一系列化学反应、净化程序以及将原料转化为所需的成品。在此过程中会产生各种中间化合物，每种中间化合物都是最终 API 的垫脚石。这些中间体可能具有独特的化学特性、结构和应用。

全球 API 中间体市场动态

驱动程序

  • 制药业蓬勃发展

由于人口老龄化、医疗成本上升以及对新颖和有创意的治疗方法的需求等因素，全球制药业仍在增长。这种扩张刺激了对 API 中间体的需求，而 API 中间体是药品生产的关键成分。

  • 不断进步的技术

化学合成和工艺技术的发展提高了 API 中间体的制造效率和成本效益，从而推动了市场扩张。

  • 生物制药需求不断增长

随着重组蛋白和单克隆抗体等生物制药的兴起，对生物工艺中间体的需求也随之增加。这些工艺步骤对于生产生物制剂必不可少，有助于推动市场增长。

机会

  • 个性化医疗需求不断增长

个性化医疗和靶向药物的趋势要求开发针对特定患者情况定制的 API 和中间体，这可以刺激该领域的研究和开发。

  • 加强合作与伙伴关系

API 中间体生产商、制药公司和研究机构之间的合作可以带来创新解决方案并进入新市场。

  • 更加关注绿色和可持续化学

随着可持续性和环保实践受到越来越多的关注，API中间体生产商有机会创造和提供更加绿色、更加可持续的化学工艺和中间体。

限制/挑战

  • 严格规定

在制药行业，严格的监管规定可能是一个主要障碍。遵守和保持良好生产规范 (GMP) 等规定可能既昂贵又耗时，并且会限制市场增长。

  • 供应链中断

由于许多制造商依赖复杂的全球供应商网络来获取原材料和中间体，全球 API 中间体市场很容易受到供应链中断的影响。供应链可能会受到自然灾害或政治动荡等不可预见的情况的阻碍。

  • 安全问题

首要任务是确保工业流程的安全性和员工的安全。化学合成过程中可能会使用危险物质和反应。

  • 成本高昂  

原材料和化学品的价格和供应情况的变化会影响 API 中间体制造的成本效益和供应链稳定性。

本全球 API 中间体市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关全球 API 中间体市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

全球 API 中间体市场范围

全球 API 中间体市场根据类型、产品、治疗类别、客户、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

类型

  • 兽药中间体
  • 制药/原料药中间体

产品

  • 溴化合物
  • 邻苄基沙丁胺醇
  • 半硫酸盐
  • 环氧乙烷
  • 比索洛尔碱
  • 手性 PCBHP
  • 苯海拉明碱
  • 氯苯那敏碱
  • 溴苯那敏碱
  • 美吡拉敏/吡拉明碱
  • 6-氨基-1,3-二甲基尿嘧啶
  • 茶碱
  • 乙酰茶碱
  • 黄嘌呤
  • 腈类
  • 其他的

治疗类型

  • 自身免疫性疾病
  • 肿瘤学
  • 代谢疾病
  • 眼科
  • 心血管疾病
  • 传染病
  • 神经病学
  • 呼吸系统疾病
  • 皮肤科
  • 泌尿科
  • 其他的

顾客

  • 直接用户/制药公司
  • 贸易商/批发商/分销商
  • 协会/政府机构/私人机构

最终用户

  • API 制造商
  • 成品制造商

分销渠道

  • 直接招标
  • 零售销售
  • 其他的

全球 API 中间体市场区域分析/见解

对全球 API 中间体市场进行分析，并根据上述国家、类型、产品、治疗类型、客户、最终用户和分销渠道提供市场规模信息。  

全球 API 中间体市场报告涵盖的国家包括美国、加拿大、墨西哥、德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、奥地利、挪威、匈牙利、立陶宛、爱尔兰、波兰、欧洲其他地区、日本、中国、澳大利亚、印度、韩国、新加坡、印度尼西亚、泰国、马来西亚、菲律宾、越南、亚太其他地区、巴西、阿根廷、秘鲁、南美洲其他地区、沙特阿拉伯、南非、阿联酋、以色列、科威特、埃及以及中东和非洲其他地区。

北美在全球 API 中间体市场占据主导地位，预计在 2023 年至 2030 年的预测期内将以最高的增长率增长，这得益于医疗保健支出的增加以及制药/原料药中间体领域的完善的医疗保健基础设施。

亚太地区引领着全球 API 中间体市场的增长，而制药/原料药中间体领域在该国占据主导地位，因为低成本 API 中间体的供应量增加。由于对 API 中间体的消费需求不断增加，德国的制药/原料药中间体领域在全球 API 中间体市场中占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。

医疗保健基础设施增长安装基础和新技术渗透

 全球 API 中间体市场还为您提供详细的市场分析，用于患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响，以创建更稳健、更队列的多元统计模型，用于预测 2023-2030 年增长期的市场。

竞争格局和 API 中间体市场份额分析

 全球 API 中间体市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对全球 API 中间体市场的关注有关。

全球 API 中间体市场的一些主要参与者包括：

  • HIKAL 有限公司 (印度)
  • Cambrex 公司 (美国)
  • Ganesh-Group、AlzChem Group AG（印度）
  • Vasudha Pharma（印度）
  • 安阳通用化工有限公司（中国）
  • Sarex（印度）
  • Sandoo 制药和化学品有限公司 (印度)
  • Atul 有限公司 (印度)
  • Sandoz International GmbH（诺华公司的子公司）（德国）
  • Aceto（美国）
  • Supriya Lifescience Ltd.（印度）
  • 利华化工有限公司 (中国)
  • Vertellus（美国）
  • Dishman Carbogen Amcis Ltd（印度）
  • 赛诺菲（法国）
  • Divi's Laboratories Limited（印度）
  • AARTI INDUSTRIES LIMITED（印度）
  • Aurobindo Pharma（印度）
  • 巴斯夫公司（德国）

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL API intermediates MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
    1. CURRENT SCENARIO OF IMPORT AND EXPORT OF API INTERMEDIATE
    2. Tentative Production and operational costs calculations which will ultimately lead to feasibility of the product manufacturing
      1. Tentative Land requirement for a Substantial Production Capacity Plant Set-Up
    3. GLOBAL API INTERMEDIATES MARKET: 3C ANALYSIS-CHINA EFFECT
      1. THE U.S.-CHINA TRADE WAR
      2. INDO-CHINA GEOPOLITICAL ISSUES
      3. CHINESE SLOWDOWN DUE TO E&C OVER THE YEARS
      4. CHINESE SLOWDOWN DUE TO COVID-19 (CORONAVIRUS)
    4. Cost Analysis
    5. Analysis on China API intermediates:
      1. Conclusion:
    6. porters five forces model
    7. Pestel analysis
    8. global API INTERMEDIATES market: regulatORY
      1. THE U.S. REGULATORY GUIDANCE FOR NON-CLINICAL SAFETY EVALUATION OF API INTERMEDIATES
      2. CANADA REGULATORY GUIDANCE FOR API INTERMEDIATES
      3. EUROPE REGULATORY SCENARIO FOR API INTERMEDIATES
      4. JAPAN REGULATORY FOR API INTERMEDIATES
      5. MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR API INTERMEDIATES
  5. GLOBAL API INTERMEDIATES MARKET: CONCLUSION
    1. TOP PRODUCTS AND THERAPEUTIC AREAS
    2. ADDITIONAL
  6. CUSTOMER SENTIMENTS/INCLINATION TOWARDS FINDING ALTERNATE VENDOR SOURCE
  7. LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE:
  8. Market Overview
    1. Drivers
      1. HIGH BURDEN OF CHRONIC DISEASES
      2. increase in aging population
      3. utilization of advanceD technology in active pharmaceutical ingredients (api) manufacturing
      4. increasing disease awareness and education
      5. research and development regarding pharmaceutical API and their intermediates
    2. restrainTs
      1. availability of sub-standard and counterfeit drugs
      2. product recalls
      3. high manufacturing cost
      4. stringent government regulations for api intermediates
    3. opportunities
      1. strategic initiatives by the market players
      2. increasing healthcare expenditure
      3. SOARING NUMBER OF API INTERMEDIATES MANUFACTURERS
      4. RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (crO)
    4. challenges
      1. disruption in the supply chain of active pharmaceutical ingredients (api) during covid-19
      2. lack of workforce in pharma industries
  9. Impact of COVID 19 on Global API Intermediates market
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
    5. CONCLUSION
  10. global API intermediates MARKET, BY type
    1. overview
    2. pharmaceutical intermediates/ bulk drug intermediates
    3. Veterinary Drug Intermediates
  11. global API intermediates MARKET, BY product
    1. overview
    2. Nitriles
    3. bromo compound
    4. Chiral PCBHP
    5. Chlorpheniramine Base
    6. Brompheniramine Base
    7. Pheniramine Base
    8. O-Benzyl Salbutamol
    9. Bisoprolol Base
    10. Hemisulfate
    11. Oxirane
    12. Mepyramine/Pyrilamine Base
    13. Theofylline
    14. Acefylline
    15. Xanthine
    16. 6-Amino-1,3-Dimethyl Uracil
    17. others
  12. global API intermediates MARKET, BY therapeutic type
    1. overview
    2. Cardiovascular Diseases
    3. Metabolic Diseases
    4. infectious Diseases
    5. respiratory Diseases
    6. neurology
    7. oncology
    8. Autoimmune Disease
    9. Dermatology
    10. ophthalmology
    11. urology
    12. others
  13. global API intermediates MARKET, BY customers
    1. overview
    2. Direct Users/Pharma Companies
    3. Traders/Wholesalers/Distributors
    4. Associations/Govt. Institutions/Pvt Institutions
  14. global API intermediates MARKET, BY End User
    1. overview
    2. API manufacturer
    3. finished product manufacturer
  15. global API intermediates MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. Retail Sale
    4. others
  16. Global API Intermediates Market by geography
    1. Overview
    2. NORTH AMERICA
      1. U.S
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. GERMANY
      2. U.K
      3. ITALY
      4. SPAIN
      5. FRANCE
      6. NETHERLANDS
      7. RUSSIA
      8. SWITZERLAND
      9. TURKEY
      10. AUSTRIA
      11. NORWAY
      12. HUNGARY
      13. LITHUANIA
      14. IRELAND
      15. POLAND
      16. REST OF ASIA PACIFIC
    4. ASIA-PACIFIC
      1. CHINA
      2. INDIA
      3. JAPAN
      4. AUSTRALIA
      5. SOUTH KOREA
      6. SINGAPORE
      7. MALAYSIA
      8. THAILAND
      9. INDONESIA
      10. PHILIPPINES
      11. VIETNAM
      12. REST OF ASIA PACIFIC
    5. SOUTH AMERICA
      1. BRAZIL
      2. ARGENTINA
      3. PERU
      4. REST OF SOUTH AMERICA
    6. MIDDLE EAST & AFRICA
      1. SAUDI ARABIA
      2. SOUTH AFRICA
      3. UAE
      4. ISRAEL
      5. KUWAIT
      6. EGYPT
      7. REST OF MIDDLE EAST & AFRICA
  17. Global API Intermediates Market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  18. swot analysis
  19. company profile
    1. aurobindo pharma
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORFOLIO
      5. RECENT DEVELOPMENTS
    2. Divi’s laboratories limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. basf se
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. CAMBRIX CORPORATION
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Sandoz International GmbH (a subsidiary of Novartis AG)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. aceto
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. hikal ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. alzchem group ag
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. vertellus
      1. COMPANY SNAPSHOT
      2. PRODUCT CATEGORIES
      3. RECENT DEVELOPMENTS
    10. sanofi
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORFOLIO
      4. RECENT DEVELOPMENTS
    11. atul ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. aarti industries limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. vasudha pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. anyang general chemical co., Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORFOLIO
      3. RECENT DEVELOPMENT
    15. dishman carbogen amics ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORFOLIO
      4. RECENT DEVELOPMENTS
    16. ganesh-group
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. levachem company limited
      1. COMPANY SNAPSHOT
      2. PRODUCT PORFOLIO
      3. RECENT DEVELOPMENT
    18. sandoo pharmaceuticals and chemicals co., ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    19. sarex
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. SUPRIYA LIFESCIENCE LTD.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  20. questionnaire
  21. related reports

表格列表

TABLE 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: CUSTOMIZATION (COUNTRIES INVOLVED IN IMPORT & EXPORT)

TABLE 2 Percentage Break up of Cost

TABLE 3 Tentative Land Requirement

TABLE 4 Percentage Break up of Plant Area

TABLE 5 Table: 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE

TABLE 6 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 7 MARKET PLAYERS OF API INTERMEDIATES

TABLE 8 Sales Data of API intermediates for 2019/2020

TABLE 9 Global API intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 10 Global pharmaceutical intermediates/ bulk drug intermediates in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 11 Global Veterinary Drug Intermediates in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 12 Global API intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 13 Global nitriles in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 14 Global bromo compound in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 15 Global chiral PCBHP in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 16 Global chlorpheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 17 Global brompheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 18 Global pheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 19 Global O-Benzyl Salbutamol in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 20 Global bisoprolol base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 21 Global hemisulfate in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 22 Global oxirane in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 23 Global mepyramine/pyrilamine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 24 Global theofylline in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 25 Global acefylline in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 26 Global Xanthine in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 27 Global 6-amino-1, 3-dimethyl uracil in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 28 Global others in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 29 Global API intermediates Market, By THERAPEUTIC Type, 2019-2028 (USD Million)

TABLE 30 globaL cardiovascular diseases in API intermediates Market, By Region, 2017-2028 (USD Million)

TABLE 31 globaL metabolic diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 32 globaLinfectious diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 33 globaL respiratory diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 34 globaL neurology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 35 globaL oncology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 36 globaL autoimmune diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 37 globaL dermatology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 38 globaL ophthalmology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 39 globaL urology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 40 globaL others in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 41 Global API intermediates Market, By CUSTOMERS, 2019-2028 (USD Million)

TABLE 42 globaL Direct Users/Pharma Companies in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 43 globaL Traders/Wholesalers/Distributors in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 44 globaL Associations/Govt. Institutions/Pvt Institutionsin API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 45 Global API intermediates Market, By END USER, 2019-2028 (USD Million)

TABLE 46 Global API manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 47 Global finished product manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 48 Global API intermediates Market, By distribution channel, 2019-2028 (USD Million)

TABLE 49 globaL direct tender in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 50 globaL retail sales in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 51 globaL Othersin API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 52 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS MARKET, BY REGION , 2021-2028 (USD MILLION)

TABLE 53 NORTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 54 North America API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 55 North America API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 56 North America API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 57 North America API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 58 North America API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 59 North America API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 U.S API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 61 U.S API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 62 U.S API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 63 U.S API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 64 U.S API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 65 U.S API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 66 Canada API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 67 Canada API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 68 Canada API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 69 Canada API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 70 Canada API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 71 Canada API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 72 MEXICO API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 73 MEXICO API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 74 MEXICO API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 75 MEXICO API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 76 MEXICO API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 77 MEXICO API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 78 Europe API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 79 Europe API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 80 Europe API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 81 Europe API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 82 Europe API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 83 Europe API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 84 Europe API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 85 Germany API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 86 Germany API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 87 Germany API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 88 Germany API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 89 Germany API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 90 Germany API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 91 U.K API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 92 U.K API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 93 U.K API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 94 U.K API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 95 U.K API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 96 U.K API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 97 U.K API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 98 Italy API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 99 Italy API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 100 Italy API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 101 Italy API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 102 Italy API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 103 Spain API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 104 Spain API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 105 Spain API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 106 Spain API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 107 Spain API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 108 Spain API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 109 France API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 110 France API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 111 France API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 112 France API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 113 France API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 114 France API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 115 Netherlands API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 116 Netherlands API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 117 Netherlands API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 118 Netherlands API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 119 Netherlands API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 120 Netherlands API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 121 Russia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 122 Russia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 123 Russia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 124 Russia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 125 Russia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 126 Russia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 127 Switzerland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 128 Switzerland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 129 Switzerland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 130 Switzerland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 131 Switzerland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 132 Switzerland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 133 Turkey API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 134 Turkey API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 135 Turkey API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 136 Turkey API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 137 Turkey API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 138 Turkey API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 139 Austria API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 140 Austria API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 141 Austria API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 142 Austria API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 143 Austria API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 144 Austria API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 145 Norway API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 146 Norway API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 147 Norway API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 148 Norway API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 149 Norway API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 150 Norway API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 151 Hungary API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 152 Hungary API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 153 Hungary API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 154 Hungary API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 155 Hungary API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 156 Hungary API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 157 Lithuania API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 158 Lithuania API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 159 Lithuania API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 160 Lithuania API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 161 Lithuania API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 162 Lithuania API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 163 Ireland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 164 Ireland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 165 Ireland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 166 Ireland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 167 Ireland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 168 Ireland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 169 Poland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 170 Poland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 171 Poland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 172 Poland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 173 Poland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 174 Poland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 175 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 176 ASIA-PACIFIC API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 177 Asia-Pacific API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 178 Asia-Pacific API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 179 Asia-Pacific API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 180 Asia-Pacific API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 181 Asia-Pacific API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 182 Asia-Pacific API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 183 China API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 184 China API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 185 China API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 186 China API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 187 China API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 188 China API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 189 India API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 190 India API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 191 India API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 192 India API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 193 India API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 194 India API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 195 India API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 196 Japan API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 197 Japan API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 198 Japan API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 199 Japan API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 200 Japan API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 201 australia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 202 Australia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 203 Australia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 204 Australia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 205 Australia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 206 Australia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 207 South Korea API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 208 South Korea API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 209 South Korea API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 210 South Korea API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 211 South Korea API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 212 South Korea API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 213 Singapore API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 214 Singapore API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 215 Singapore API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 216 Singapore API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 217 Singapore API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 218 Singapore API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 219 Malaysia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 220 Malaysia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 221 Malaysia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 222 Malaysia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 223 Malaysia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 224 Malaysia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 225 Thailand API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 226 Thailand API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 227 Thailand API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 228 Thailand API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 229 Thailand API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 230 Thailand API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 231 Indonesia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 232 Indonesia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 233 Indonesia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 234 Indonesia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 235 Indonesia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 236 Indonesia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 237 Philippines API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 238 Philippines API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 239 Philippines API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 240 Philippines API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 241 Philippines API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 242 Philippines API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 243 Vietnam API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 244 Vietnam API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 245 Vietnam API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 246 Vietnam API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 247 Vietnam API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 248 Vietnam API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 249 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 250 SOUTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 251 South America API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 252 South America API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 253 South America API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 254 South America API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 255 South America API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 256 South America API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 257 BRAZIL API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 258 BRAZIL API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 259 BRAZIL API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 260 BRAZIL API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 261 BRAZIL API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 262 BRAZIL API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 263 Argentina API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 264 Argentina API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 265 Argentina API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 266 Argentina API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 267 Argentina API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 268 Argentina API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 269 PERU API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 270 PERU API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 271 PERU API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 272 PERU API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 273 PERU API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 274 PERU API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 275 Rest of South America API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 276 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 277 Middle East & Africa API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 278 Middle East & Africa API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 279 Middle East & Africa API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 280 Middle East & Africa API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 281 Middle East & Africa API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 282 Middle East & Africa API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 283 Saudi Arabia API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 284 Saudi Arabia API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 285 Saudi Arabia API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 286 Saudi Arabia API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 287 Saudi Arabia API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 288 Saudi Arabia API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 289 South Africa API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 290 South Africa API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 291 South Africa API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 292 South Africa API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 293 South Africa API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 294 South Africa API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 295 UAE API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 296 UAE API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 297 UAE API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 298 UAE API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 299 UAE API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 300 UAE API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 301 Israel API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 302 Israel API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 303 Israel API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 304 Israel API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 305 Israel API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 306 Israel API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 307 Kuwait API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 308 Kuwait API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 309 Kuwait API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 310 Kuwait API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 311 Kuwait API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 312 Kuwait API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 313 Egypt API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 314 Egypt API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 315 Egypt API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 316 Egypt API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 317 Egypt API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 318 Egypt API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 319 Rest of Middle East & Africa API Intermediates Market, By Type, 2019-2028 (USD Million)

图片列表

FIGURE 1 Global API INTERMEDIATES MARKET: SEGMENTATION

FIGURE 2 GLOBAL API INTERMEDIATES MARKET: DATA TRIANGULATION

FIGURE 3 global API intermediates Market: DROC ANALYSIS

FIGURE 4 Global API intermediates market: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 Global API intermediates Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL API intermediates MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL API intermediates MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL API INTERMEDIATES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL API INTERMEDIATES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL API intermediates MARKET: MARKET type COVERAGE GRID

FIGURE 11 Global API intermediates market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL API intermediates market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 north america is the fastest growing market FOR the API intermediates MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 Utilization of advanceD technology in active pharmaceutical ingredients (API) manufacturing is DRIVing THE global API intermediates MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 15 pharmaceutical / bulk drug intermediates SEGMENT is expected to account for the largest share of the global API INTERMEDIATES MARKET in 2021 & 2028

FIGURE 16 DRIVERS, RESTRAINTs, OPPORTUNITies AND CHALLENGEs OF Global API Intermediates market

FIGURE 17 TOP 5 COUNTRIES FOR NUMBER OF PEOPLE AGED 20 TO 79 SUFFERING FROM DIABETES in 2019

FIGURE 18 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN FEMALE POPULATION in 2020

FIGURE 19 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN MALE POPULATION in 2020

FIGURE 20 10 GLOBAL CAUSES OF DEATHs WITH THE CHRONIC DISEASES

FIGURE 21 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS in 2020 (IN MILLIONS)

FIGURE 22 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)

FIGURE 23 global API intermediates market: BY type, 2021

FIGURE 24 global API intermediates market: BY type, 2019-2028 (USD Million)

FIGURE 25 global API intermediates market: BY type, CAGR (2021-2028)

FIGURE 26 global API intermediates market: BY type, LIFELINE CURVE

FIGURE 27 global API intermediates market: BY product, 2021

FIGURE 28 global API intermediates market: BY product, 2019-2028 (USD Million)

FIGURE 29 global API intermediates market: BY product, CAGR(2021-2028)

FIGURE 30 global API intermediates market: BY product, LIFELINE CURVE

FIGURE 31 global API intermediates market: BY therapeutic type, 2021

FIGURE 32 global API intermediates market: BY therapeutic type, 2019-2028 (USD Million)

FIGURE 33 global API intermediates market: BY therapeutic type, CAGR (2021-2028)

FIGURE 34 global API intermediates market: BY therapeutic type, LIFELINE CURVE

FIGURE 35 global API intermediates market: BY customers, 2021

FIGURE 36 global API intermediates market: BY customers, 2019-2028 (USD Million)

FIGURE 37 global API intermediates market: BY customers, CAGR (2021-2028)

FIGURE 38 global API intermediates market: BY customers, LIFELINE CURVE

FIGURE 39 global API intermediates market: BY end user, 2021

FIGURE 40 global API intermediates market: BY end user, 2019-2028 (USD Million)

FIGURE 41 global API intermediates market: BY end user, CAGR (2021-2028)

FIGURE 42 global API intermediates market: BY end user, LIFELINE CURVE

FIGURE 43 global API intermediates market: BY distribution channel, 2021

FIGURE 44 global API intermediates market: BY distribution channel, 2019-2028 (USD Million)

FIGURE 45 global API intermediates market: BY distribution channel, CAGR (2021-2028)

FIGURE 46 global API intermediates market: BY distribution channel, LIFELINE CURVE

FIGURE 47 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: SNAPSHOT (2020)

FIGURE 48 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2020)

FIGURE 49 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2021 & 2028)

FIGURE 50 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2020 & 2028)

FIGURE 51 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY type (2021-2028)

FIGURE 52 North America API Intermediates market: SNAPSHOT (2020)

FIGURE 53 North America API Intermediates market: BY COUNTRY (2020)

FIGURE 54 North America API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 55 North America API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 56 North America API Intermediates market: BY type (2021-2028)

FIGURE 57 Europe API Intermediates market: SNAPSHOT (2020)

FIGURE 58 Europe API INTERMEDIATEs market: BY COUNTRY (2020)

FIGURE 59 Europe API INTERMEDIATEs market: BY COUNTRY (2021 & 2028)

FIGURE 60 Europe API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 61 Europe API Intermediates market: BY type (2021-2028)

FIGURE 62 Asia-Pacific API Intermediates market: SNAPSHOT (2020)

FIGURE 63 Asia-Pacific API Intermediates market: BY COUNTRY (2020)

FIGURE 64 Asia-Pacific API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 65 Asia-Pacific API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 66 Asia-Pacific API Intermediates market: BY type (2021-2028)

FIGURE 67 South America API Intermediates market: SNAPSHOT (2020)

FIGURE 68 South America API Intermediates market: BY COUNTRY (2020)

FIGURE 69 South America API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 70 South America API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 71 South America API Intermediates market: BY type (2021-2028)

FIGURE 72 Middle East & Africa API Intermediates market: SNAPSHOT (2020)

FIGURE 73 Middle East & Africa API Intermediates market: BY COUNTRY (2020)

FIGURE 74 Middle East & Africa API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 75 Middle East & Africa API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 76 Middle East & Africa API Intermediates market: BY type (2021-2028)

FIGURE 77 Global API Intermediates market: company share 2020 (%)

FIGURE 78 North America API Intermediates Market: company share 2020 (%)

FIGURE 79 EUROPE API Intermediates Market: company share 2020 (%)

FIGURE 80 ASIA-PACIFIC API Intermediates Market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global API Intermediates Market, By Type (Veterinary Drug Intermediates, Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others) - Industry Trends and Forecast to 2030. .
The Global Api Intermediates Market size was valued at USD 2.34 USD Billion in 2022.
The Global Api Intermediates Market is projected to grow at a CAGR of 7.1% during the forecast period of 2023 to 2030.
The major players operating in the market include HIKAL Ltd, Cambrex Corporation, Ganesh Group, AlzChem Group AG, Vasudha Pharma, Anyang General Chemical Co., Sarex, Sandoo Pharmaceuticals and Chemicals Co., Atul Ltd, Sandoz International GmbH, Aceto, Supriya Lifescience , LEVACHEM COMPANY LIMITED, Vertellus, Dishman Carbogen Amcis Ltd, Sanofi, Divi's Laboratories Limited, AARTI INDUSTRIES LIMITED, Aurobindo Pharma, BASF SE.
The market report covers data from the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa.

浏览相关页面

Banner